Stocks

Top Analyst Stocks

Top Smart Score Stocks

Top Insiders Stocks Top Stock Websites Top Gainers/ Losers/ Active Stocks Dividend Stocks ChatGPT Stocks

ETFs

ETF Center Top ETFs by Upside

Top ETFs by Smart Score Top Gainers/ Losers/ Active ETFs

Crypto

Crypto Center Bitcoin

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks TipRanks Community Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

Follow Us

News Smart Portfolio Expert Center TipRanksAI

TOOLS

Earnings Calendar

STOCKS

ADVANCED RESEARCH

TipRanks Premium

Invest Like a Pro with Unique Data & Simplifed ToolsTry Now

Stocks

Top Analyst Stocks

Top Smart Score Stocks

Top Insiders Stocks

Top Stock Websites

Top Gainers/ Losers/ Active Stocks

Dividend Stocks

ETFs

Top ETFs by Upside

Top ETFs by Smart Score

Top Gainers/ Losers/ Active ETFs

Crypto

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Enterprise Solutions

Plans & Pricing

Education

About Us

TipRanks Community

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Follow Us

PLRX Stock Latest News

Pliant Therapeutics price target raised to $52 from $50 at H.C. Wainwright

The FlyPliant Therapeutics price target raised to $52 from $50 at H.C. Wainwright

Pliant announces Phase 2a INTEGRIS-PSC met primary, secondary endpoints

The FlyPliant announces Phase 2a INTEGRIS-PSC met primary, secondary endpoints

7d ago

Pliant Therapeutics to Host Investor Call and Webcast to Discuss Interim Results from INTEGRIS-PSC, a Phase 2a Trial in Patients with Primary Sclerosing Cholangitis

Press ReleasesPliant Therapeutics to Host Investor Call and Webcast to Discuss Interim Results from INTEGRIS-PSC, a Phase 2a Trial in Patients with Primary Sclerosing Cholangitis

7d ago

Pliant Therapeutics appoints Kuo as Chief Development Officer

The FlyPliant Therapeutics appoints Kuo as Chief Development Officer

18d ago

Pliant Therapeutics to Participate in Upcoming Investor Conferences

Press ReleasesPliant Therapeutics to Participate in Upcoming Investor Conferences

1M ago

Pliant Therapeutics Announces Three Upcoming Presentations at the European Respiratory Society International Congress 2023

Press ReleasesPliant Therapeutics Announces Three Upcoming Presentations at the European Respiratory Society International Congress 2023

Pliant Therapeutics management to meet with Oppenheimer

The FlyPliant Therapeutics management to meet with Oppenheimer

2M ago

Pliant Therapeutics price target lowered to $54 from $57 at RBC Capital

The FlyPliant Therapeutics price target lowered to $54 from $57 at RBC Capital

2M ago

Pliant Therapeutics reports Q2 EPS (70c), consensus (71c)

The FlyPliant Therapeutics reports Q2 EPS (70c), consensus (71c)

2M ago

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results

Press ReleasesPliant Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results

2M ago

Pliant Therapeutics announces initiation of BEACON-IPF

The FlyPliant Therapeutics announces initiation of BEACON-IPF

2M ago

Pliant Therapeutics Announces Initiation of BEACON-IPF, a Phase 2b Clinical Trial of Bexotegrast in Idiopathic Pulmonary Fibrosis

Press ReleasesPliant Therapeutics Announces Initiation of BEACON-IPF, a Phase 2b Clinical Trial of Bexotegrast in Idiopathic Pulmonary Fibrosis

2M ago

Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Association for the Study of the Liver (EASL) International Liver Congress™

Press ReleasesPliant Therapeutics Presents Data from its Bexotegrast Program at the European Association for the Study of the Liver (EASL) International Liver Congress™

Pliant Therapeutics presents data from its bexotegrast program at EASL

The FlyPliant Therapeutics presents data from its bexotegrast program at EASL

3M ago

Over 100% Upside: Analysts See an Appealing Entry Point in These 2 Small-Cap Stocks

Stock Analysis & IdeasOver 100% Upside: Analysts See an Appealing Entry Point in These 2 Small-Cap Stocks

4M ago

Trending

S&P 500

Dow Jones

Nasdaq 100

More Trending Stocks >